Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

P. Karayiannis; S. Kanatakis; H. C. Thomas

doi:10.1016/0168-8278(90)90145-H

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

P. Karayiannis, S. Kanatakis, H. C. Thomas

Medical School

Imperial College London

Research output: Contribution to journal › Article › peer-review

Abstract

The antibody response to hepatitis B surface antigen (anti-HBs) was studied in 15 chronic hepatitis B virus (HBV)-infected patients who seroconverted following treatment with alpha interferon. The levels of anti-HBs ( IU l) attained were significantly lower than those recorded in patients with convalescent symptomatic or asymptomatic acute infection and in hospital personnel who received a plasma derived HBV vaccine.

Original language	English
Pages (from-to)	350-352
Number of pages	3
Journal	Journal of Hepatology
Volume	10
Issue number	3
DOIs	https://doi.org/10.1016/0168-8278(90)90145-H
Publication status	Published - 1990

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/0168-8278(90)90145-H

Cite this

@article{3d294f8cf74d46ff9783d20b4499584c,

title = "Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment",

abstract = "The antibody response to hepatitis B surface antigen (anti-HBs) was studied in 15 chronic hepatitis B virus (HBV)-infected patients who seroconverted following treatment with alpha interferon. The levels of anti-HBs ( IU l) attained were significantly lower than those recorded in patients with convalescent symptomatic or asymptomatic acute infection and in hospital personnel who received a plasma derived HBV vaccine.",

author = "P. Karayiannis and S. Kanatakis and Thomas, \{H. C.\}",

year = "1990",

doi = "10.1016/0168-8278(90)90145-H",

language = "English",

volume = "10",

pages = "350--352",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

AU - Karayiannis, P.

AU - Kanatakis, S.

AU - Thomas, H. C.

PY - 1990

Y1 - 1990

N2 - The antibody response to hepatitis B surface antigen (anti-HBs) was studied in 15 chronic hepatitis B virus (HBV)-infected patients who seroconverted following treatment with alpha interferon. The levels of anti-HBs ( IU l) attained were significantly lower than those recorded in patients with convalescent symptomatic or asymptomatic acute infection and in hospital personnel who received a plasma derived HBV vaccine.

AB - The antibody response to hepatitis B surface antigen (anti-HBs) was studied in 15 chronic hepatitis B virus (HBV)-infected patients who seroconverted following treatment with alpha interferon. The levels of anti-HBs ( IU l) attained were significantly lower than those recorded in patients with convalescent symptomatic or asymptomatic acute infection and in hospital personnel who received a plasma derived HBV vaccine.

UR - https://www.scopus.com/pages/publications/0025276179

U2 - 10.1016/0168-8278(90)90145-H

DO - 10.1016/0168-8278(90)90145-H

M3 - Article

C2 - 2142176

AN - SCOPUS:0025276179

SN - 0168-8278

VL - 10

SP - 350

EP - 352

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 3

ER -

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this